Effective suppression of brequinar sodium on accelerated allograft rejection in presensitized recipients.
Nozaki
S
S
First Department of Surgery, Osaka University Medical School, Japan.
Ito
T
T
Kamiike
W
W
Uchikoshi
F
F
Ito
A
A
Kuhara
A
A
Nakata
S
S
Shirakura
R
R
Miyata
M
M
Matsuda
H
H
D000818:Animals; D001713:Biphenyl Compounds / Q000627:therapeutic use*; D003165:Complement System Proteins / Q000276:immunology; D003602:Cytotoxicity, Immunologic; D005434:Flow Cytometry; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival / Q000187:drug effects; D016027:Heart Transplantation / Q000276:immunology*; D007114:Immunization; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008213:Lymphocyte Activation; D008297:Male; D051381:Rats; D011915:Rats, Inbred BUF; D011917:Rats, Inbred Lew; D016038:Skin Transplantation / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology; D014184:Transplantation, Homologous; D011798:Quinaldines
D001713:Biphenyl Compounds; D003165:Complement System Proteins; D007166:Immunosuppressive Agents; C046943:brequinar; D011798:Quinaldines